Addiction and Hallucinogens

The worldwide use of psychoactive substances remains a major public health problem. It has spread in an unusual way in recent times. The methodology of this book was based on taking information from its source where a sample of consumers of psychoactive substances (hallucinogens). The patient profile is characterized by their young age (48%) young adults [21-25 years] male predominance (82%) versus (18%) females. Pregabalin® was the most commonly used substance (59%) followed by Tramadol® (18%). The distribution of patients according to daily dose shows a high rate of 2 doses per day (35%) with an age of consumption of more than 5 years central nervous system disorders (33%) and other disorders. Management is marked by the presence of a relatively good treatment protocol in the department despite the absence of excellent conditions for treatment and drug testing.